(Q37522358)

20 August 2017

1 reference

title

Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence (English)

1 reference

major depressive disorder

20 August 2017

1 reference

1 reference

Andrew F Leuchter

1

1 reference

20 August 2017

Ian A Cook

series ordinal

2

1 reference

20 August 2017

Aimee Hunter

series ordinal

3

1 reference

20 August 2017

Alex Korb

series ordinal

4

1 reference

20 August 2017

language of work or name

1 reference

1 April 2009

1 reference

Clinical EEG and Neuroscience

20 August 2017

published in

1 reference

20 August 2017

volume

40

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

78-83

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

The National Comorbidity Survey Replication (NCS-R): background and aims.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

The economics of women and depression: an employer's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Validity of clinical trials of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Continuity of antidepressant treatment for adults with depression in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Effect of primary care treatment of depression on service use by patients with high medical expenditures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Cingulate function in depression: a potential predictor of treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Electrophysiology of the frontal granular cortex. III. The cingulate-prefrontal relation in primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

White matter injury, neural connectivity and the pathophysiology of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Cingulate cortex of the rhesus monkey: II. Cortical afferents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Medial prefrontal cortex generates frontal midline theta rhythm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Coupling of theta activity and glucose metabolism in the human rostral anterior cingulate cortex: an EEG/PET study of normal and depressed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

The selectively distributed theta system: functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Expression, control, and probable functional significance of the neuronal theta-rhythm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Human anterior and frontal midline theta and lower alpha reflect emotionally positive state and internalized attention: high-resolution EEG investigation of meditation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Non-linear dynamic complexity of the human EEG during meditation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Disruption of early event-related theta synchronization of human EEG in alexithymics viewing affective pictures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Frontal midline theta rhythm is correlated with cardiac autonomic activities during the performance of an attention demanding meditation procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Auditory-evoked potentials as indicator of brain serotonergic activity--first evidence in behaving cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Prediction of treatment response in major depression: integration of concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Quantitative EEG in the prediction of antidepressant response to imipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Relationship between brain electrical activity and cortical perfusion in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Prefrontal changes and treatment response prediction in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Early changes in prefrontal activity characterize clinical responders to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Changes in brain function during administration of venlafaxine or placebo to normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

Functional connectivity of the anterior cingulate cortex within the human frontal lobe: a brain-mapping meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005940904000207

10.1177/155005940904000207

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference